ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Texas Permanent School Fund Corp

Texas Permanent School Fund Corp decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 14.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,177 shares of the medical instruments supplier’s stock after selling 2,531 shares during the quarter. Texas Permanent School Fund Corp owned approximately 0.06% of ICU Medical worth $1,802,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Motco acquired a new stake in shares of ICU Medical in the first quarter valued at approximately $29,000. Innealta Capital LLC acquired a new stake in shares of ICU Medical in the second quarter valued at approximately $32,000. GAMMA Investing LLC increased its stake in shares of ICU Medical by 75.1% in the first quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 133 shares during the period. EntryPoint Capital LLC increased its stake in shares of ICU Medical by 731.5% in the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 395 shares during the period. Finally, Quadrant Capital Group LLC increased its stake in shares of ICU Medical by 681.6% in the fourth quarter. Quadrant Capital Group LLC now owns 594 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 518 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insider Buying and Selling

In related news, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the sale, the vice president now directly owns 4,482 shares in the company, valued at $645,901.02. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total value of $295,425.50. Following the completion of the transaction, the vice president now owns 4,482 shares of the company’s stock, valued at approximately $645,901.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Daniel Woolson sold 2,502 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now directly owns 13,107 shares of the company’s stock, valued at approximately $2,139,324.54. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,552 shares of company stock worth $4,537,802. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Trading Down 0.0 %

Shares of NASDAQ:ICUI opened at $176.22 on Thursday. The stock has a market capitalization of $4.29 billion, a price-to-earnings ratio of -72.27 and a beta of 0.65. ICU Medical, Inc. has a 1-year low of $78.28 and a 1-year high of $181.87. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 2.41. The company has a 50 day moving average price of $146.75 and a 200 day moving average price of $120.07.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.56. The firm had revenue of $596.50 million during the quarter, compared to analysts’ expectations of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $1.58 earnings per share. On average, research analysts anticipate that ICU Medical, Inc. will post 3.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on ICUI. Raymond James raised their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Thursday, August 8th. KeyCorp increased their price objective on shares of ICU Medical from $136.00 to $147.00 and gave the company an “overweight” rating in a report on Thursday, August 8th. Finally, StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, ICU Medical currently has an average rating of “Moderate Buy” and an average target price of $149.00.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.